Back
Bright Horizons Family Solutions Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
78
BFAM
Bright Horizons Family Solutions
Last Price:
109.82
Seasonality Move:
3.3%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
157.93
Seasonality Move:
18.65%
Buy
78
Bright Horizons Family Solutions (BFAM)
is a Buy
Is Bright Horizons Family Solutions a Buy, Sell or Hold?
- The current Bright Horizons Family Solutions [BFAM] share price is $110.08. The Score for BFAM is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- BFAM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.74. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BFAM Stock Price Chart
What is Bright Horizons Family Solutions's stock price today?
-
The Bright Horizons Family Solutions share price today is $110.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BFAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
BFAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 59.24 | Buy |
Chaikin Money Flow: | 344699 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.47 - 108.49) | Buy |
Bollinger Bands (100): | (104.11 - 113.89) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.67 | Buy |
Relative Strength Index (14 RSI): | 68.69 | Buy |
Chaikin Money Flow: | -86202 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (114.06 - 147.06) | Buy |
Bollinger Bands (100): | (118.53 - 137.75) | Buy |
BFAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.82 | Buy |
20-day SMA: | 105.99 | Buy |
50-day SMA: | 107.61 | Buy |
200-day SMA: | 98.64 | Buy |
8-day EMA: | 106.22 | Buy |
20-day EMA: | 106.11 | Buy |
50-day EMA: | 107.17 | Buy |
200-day EMA: | 101.43 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 149.53 | Buy |
20-day SMA: | 132.97 | Buy |
50-day SMA: | 129.56 | Buy |
200-day SMA: | 115.84 | Buy |
8-day EMA: | 150.26 | Buy |
20-day EMA: | 138.97 | Buy |
50-day EMA: | 131.58 | Buy |
200-day EMA: | 121.41 | Buy |
Bright Horizons Family Solutions Earnings Growth & BFAM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.81 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Bright Horizons Family Solutions Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |